...
首页> 外文期刊>Biomaterials >The synergistic effects of lysophosphatidic acid receptor agonists and calcitriol on MG63 osteoblast maturation at titanium and hydroxyapatite surfaces.
【24h】

The synergistic effects of lysophosphatidic acid receptor agonists and calcitriol on MG63 osteoblast maturation at titanium and hydroxyapatite surfaces.

机译:溶血磷脂酸受体激动剂和骨化三醇对钛和羟基磷灰石表面MG63成骨细胞成熟的协同作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Successful osseointegration stems from the provision of a mechanically competent mineralised matrix at the implant site. Mature osteoblasts are the cells responsible for achieving this and a key factor for ensuring healthy bone tissue is associated with prosthetic materials will be 1 alpha,25 dihydroxy vitamin D3 (calcitriol). However it is known that calcitriol per se does not promote osteoblast maturation, rather the osteoblasts need to be in receipt of calcitriol in combination with selected growth factors in order to undergo a robust maturation response. Herein we report how agonists of the lysophosphatidic acid (LPA) receptor, LPA and (2S)-OMPT, synergistically co-operate with calcitriol to secure osteoblast maturation for cells grown upon two widely used bone biomaterials, titanium and hydroxyapatite. Efforts could now be focussed on functionalizing these materials with LPA receptor agonists to support in vivo calcitriol-induced osseointegration via heightened osteoblast maturation responses.
机译:成功的骨整合源自在植入部位提供机械有效的矿化基质。成熟的成骨细胞是负责实现这一目标的细胞,而确保健康的骨组织与假体材料相关的关键因素将是1 alpha,25二羟基维生素D3(骨化三醇)。然而,众所周知,骨化三醇本身不能促进成骨细胞的成熟,相反,成骨细胞必须接受骨化三醇与选定的生长因子的结合才能接受强健的成熟反应。本文中,我们报告了溶血磷脂酸(LPA)受体,LPA和(2S)-OMPT的激动剂如何与骨化三醇协同合作,以确保在两种广泛使用的骨生物材料钛和羟基磷灰石上生长的细胞的成骨细胞成熟。现在可以集中精力用LPA受体激动剂对这些材料进行功能化,以通过增强的成骨细胞成熟反应来支持体内骨化三醇诱导的骨整合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号